The Patent Finder
US

Vaccine for Eliciting Immune Response Comprising Lipid Formulations and RNA Encoding Multiple Immunogens

US 11,638,694 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jun 7, 2031 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 11,690,861, US 11,690,862, US 11,690,863, US 11,690,864, US 11,690,865, US 11,696,923, US 11,707,482, US 11,717,529, US 11,730,754, US 11,759,475, US 11,857,562, US 11,865,080), so the cap could be lower.

Filed Jun 23, 2022 as application 17/848,299 · Granted May 2, 2023
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
20 years from filing
2011 2031
Clock starts
Jul 6, 2011
Term ends
Jun 7, 2031
Granted
May 2, 2023
base term after the term ends fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 11,324,770, US 11,596,645, US 11,638,693, US 11,690,861, US 11,690,862, US 11,690,863, US 11,690,864, US 11,690,865, US 11,696,923, US 11,707,482, US 11,717,529, US 11,730,754, US 11,759,475, US 11,786,467, US 11,839,686, US 11,857,562, US 11,865,080, US 9,254,265.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
16
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 6, 2011, when application PCT/US2011/043105, the earliest non-provisional in its chain, was filed (this one was filed Jun 23, 2022)Jul 6, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 11,324,770, US 11,596,645, US 11,638,693, US 11,690,861, US 11,690,862, US 11,690,863, US 11,690,864, US 11,690,865, US 11,696,923, US 11,707,482, US 11,717,529, US 11,730,754, US 11,759,475, US 11,786,467, US 11,839,686, US 11,857,562, US 11,865,080, US 9,254,265)capped to Jun 7, 2031Medium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJun 7, 2031Medium confidence

This family

Application PCT/US2011/043105PCT application
no patent term
no patent term
Application 13/808,080Abandoned
not computed
not computed
US 11,786,467In force
Jun 2031
Jun 2031
US 11,839,686In force
Jun 2031
Jun 2031
US 11,766,401In force
Jun 2031
Jun 2031
Application 17/560,092Abandoned
not computed
not computed
Application 17/560,116Abandoned
not computed
not computed
US 11,666,534In force
Jun 2031
Jun 2031
8 of 16 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 2, 2022
Reel 60702, frame 100
Novartis Vaccines and Diagnostics, Inc.Novartis AGAssignment of Assignor's Interest
Aug 2, 2022
Reel 60702, frame 138
Novartis AGGlaxoSmithKline Biologicals S.A.Assignment of Assignor's Interest
Aug 2, 2022
Reel 60702, frame 178
Geall, AndrewNovartis Vaccines and Diagnostics, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited